E Fund Management Co. Ltd. Increases Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

E Fund Management Co. Ltd. grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,556 shares of the company’s stock after buying an additional 294 shares during the quarter. E Fund Management Co. Ltd.’s holdings in GE HealthCare Technologies were worth $507,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Jennison Associates LLC increased its position in GE HealthCare Technologies by 49.4% during the 4th quarter. Jennison Associates LLC now owns 1,208,830 shares of the company’s stock worth $93,467,000 after purchasing an additional 399,961 shares in the last quarter. South Dakota Investment Council increased its position in GE HealthCare Technologies by 272.1% during the 4th quarter. South Dakota Investment Council now owns 98,262 shares of the company’s stock worth $7,598,000 after purchasing an additional 71,857 shares in the last quarter. Cerity Partners LLC increased its position in GE HealthCare Technologies by 27.2% during the 4th quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock worth $3,551,000 after purchasing an additional 9,809 shares in the last quarter. Fifth Third Bancorp increased its position in GE HealthCare Technologies by 3.9% during the 4th quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock worth $2,600,000 after purchasing an additional 1,250 shares in the last quarter. Finally, Douglas Lane & Associates LLC increased its position in GE HealthCare Technologies by 22.1% during the 4th quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock worth $33,731,000 after purchasing an additional 79,073 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.4 %

Shares of NASDAQ GEHC traded down $0.32 during midday trading on Wednesday, hitting $81.11. The stock had a trading volume of 2,747,872 shares, compared to its average volume of 3,430,118. The company has a market capitalization of $37.02 billion, a price-to-earnings ratio of 23.72, a PEG ratio of 2.86 and a beta of 1.26. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. The company has a fifty day moving average price of $87.81 and a 200 day moving average price of $79.30.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, meeting the consensus estimate of $0.90. The business had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company’s revenue was down 1.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.85 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.15%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Insider Buying and Selling

In related news, insider Frank R. Jimenez purchased 1,315 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, May 1st. The shares were purchased at an average cost of $76.52 per share, with a total value of $100,623.80. Following the transaction, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts recently commented on GEHC shares. Morgan Stanley lifted their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research report on Monday, February 12th. Argus lifted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Citigroup lifted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Mizuho lowered their price target on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Finally, Bank of America lowered their price target on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.